Implications of sleep disturbance and inflammation for Alzheimer's disease dementia

The Lancet Neurology

Volumn 18, Issue 3, 2019, Pages 296-306

  Irwin, Michael R ^a   Vitiello, Michael V ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN;

ADRENERGIC SYSTEM; AGING; ALZHEIMER DISEASE; DEMENTIA; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK; SLEEP DISORDER; AGED; COGNITION; COGNITIVE DEFECT; COMPLICATION; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; RISK FACTOR; SLEEP; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION; COGNITIVE DYSFUNCTION; DEMENTIA; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; RISK FACTORS; SLEEP; SLEEP WAKE DISORDERS;

EID: 85060105714     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(18)30450-2     Document Type: Review

References (103)

1. Livingston, G, Sommerlad, A, Orgeta, V, et al. Dementia prevention, intervention, and care. Lancet 390 (2017), 2673–2734.
2. Westermann, J, Lange, T, Textor, J, Born, J, System consolidation during sleep—a common principle underlying psychological and immunological memory formation. Trends Neurosci 38 (2015), 585–597.
3. Li, J, Vitiello, MV, Gooneratne, NS, Sleep in normal aging. Sleep Med Clin 13 (2018), 1–11.
4. Mander, BA, Winer, JR, Walker, MP, Sleep and human aging. Neuron 94 (2017), 19–36.
5. Krause, AJ, Simon, EB, Mander, BA, et al. The sleep-deprived human brain. Nat Rev Neurosci 18 (2017), 404–418.
6. Spira, AP, Chen-Edinboro, LP, Wu, MN, Yaffe, K, Impact of sleep on the risk of cognitive decline and dementia. Curr Opin Psychiatry 27 (2014), 478–483.
7. Mander, BA, Winer, JR, Jagust, WJ, Walker, MP, Sleep: a novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer's disease?. Trends Neurosci 39 (2016), 552–566.
8. Van Erum, J, Van Dam, D, De Deyn, PP, Sleep and Alzheimer's disease: a pivotal role for the suprachiasmatic nucleus. Sleep Med Rev 40 (2018), 17–27.
9. Spira, AP, Gamaldo, AA, An, Y, et al. Self-reported sleep and beta-amyloid deposition in community-dwelling older adults. JAMA Neurol 70 (2013), 1537–1543.
10. Irwin, MR, Opp, MR, Sleep health: reciprocal regulation of sleep and innate immunity. Neuropsychopharmacology 42 (2017), 129–155.
11. Irwin, MR, Olmstead, R, Carroll, JE, Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry 80 (2016), 40–52.
12. Heppner, FL, Ransohoff, RM, Becher, B, Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16 (2015), 358–372.
13. Wood, H, Dementia: Peripheral inflammation could be a prodromal indicator of dementia. Nat Rev Neurol, 14, 2018, 127.
14. Spira, AP, Gottesman, RF, Sleep disturbance: an emerging opportunity for Alzheimer's disease prevention?. Int Psychogeriatr 29 (2017), 529–531.
15. Irwin, MR, Why sleep is important for health: a psychoneuroimmunology perspective. Annu Rev Psychol 66 (2015), 143–172.
16. Ohayon, MM, Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6 (2002), 97–111.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition (DSM-5), 2013, American Psychiatric Association Publishing, Washington, DC, USA.
18. Gamaldo, AA, McNeely, JM, Shah, MT, Evans, MK, Zonderman, AB, Racial differences in self-reports of short sleep duration in an urban-dwelling environment. J Gerontol B Psychol Sci Soc Sci 70 (2015), 568–575.
19. Stamatakis, KA, Kaplan, GA, Roberts, RE, Short sleep duration across income, education, and race/ethnic groups: population prevalence and growing disparities during 34 years of follow-up. Ann Epidemiol 17 (2007), 948–955.
20. Kaufmann, CN, Mojtabai, R, Hock, RS, et al. Racial/ethnic differences in insomnia trajectories among U.S. older adults. Am J Geriatr Psychiatry 24 (2016), 575–584.
21. da Silva, AA, de Mello, RG, Schaan, CW, Fuchs, FD, Redline, S, Fuchs, SC, Sleep duration and mortality in the elderly: a systematic review with meta-analysis. BMJ Open, 6, 2016, e008119.
22. Vgontzas, AN, Fernandez-Mendoza, J, Liao, D, Bixler, EO, Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev 17 (2013), 241–254.
23. Cho, HJ, Lavretsky, H, Olmstead, R, Levin, MJ, Oxman, MN, Irwin, MR, Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study. Am J Psychiatry 165 (2008), 1543–1550.
24. Bao, YP, Han, Y, Ma, J, et al. Cooccurrence and bidirectional prediction of sleep disturbances and depression in older adults: meta-analysis and systematic review. Neurosci Biobehav Rev 75 (2017), 257–273.
25. Mourao, RJ, Mansur, G, Malloy-Diniz, LF, Castro Costa, E, Diniz, BS, Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: systematic review and meta-analysis. Int J Geriatr Psychiatry 31 (2016), 905–911.
26. Lo, JC, Groeger, JA, Cheng, GH, Dijk, DJ, Chee, MW, Self-reported sleep duration and cognitive performance in older adults: a systematic review and meta-analysis. Sleep Med 17 (2016), 87–98.
27. Cavuoto, MG, Ong, B, Pike, KE, Nicholas, CL, Bei, B, Kinsella, GJ, Objective but not subjective sleep predicts memory in community-dwelling older adults. J Sleep Res 25 (2016), 475–485.
28. Lim, AS, Yu, L, Kowgier, M, Schneider, JA, Buchman, AS, Bennett, DA, Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol 70 (2013), 1544–1551.
29. Lim, AS, Kowgier, M, Yu, L, Buchman, AS, Bennett, DA, Sleep fragmentation and the risk of incident Alzheimer's disease and cognitive decline in older persons. Sleep 36 (2013), 1027–1032.
30. Spira, AP, An, Y, Wu, MN, et al. Excessive daytime sleepiness and napping in cognitively normal adults: associations with subsequent amyloid deposition measured by PiB PET. Sleep, 41, 2018, zsy152.
31. Shi, L, Chen, SJ, Ma, MY, et al. Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Med Rev 40 (2018), 4–16.
32. King, E, O'Brien, JT, Donaghy, P, et al. Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias. J Neurol Neurosurg Psychiatry 89 (2018), 339–345.
33. Irwin, MR, Witarama, T, Caudill, M, Olmstead, R, Breen, EC, Sleep loss activates cellular inflammation and signal transducer and activator of transcription (STAT) family proteins in humans. Brain Behav Immun 47 (2015), 86–92.
34. Irwin, MR, Wang, M, Ribeiro, D, et al. Sleep loss activates cellular inflammatory signaling. Biol Psychiatry 64 (2008), 538–540.
35. Irwin, MR, Wang, M, Campomayor, CO, Collado-Hidalgo, A, Cole, S, Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med 166 (2006), 1756–1762.
36. Vgontzas, AN, Basta, M, Fernandez-Mendoza, J, Subjective short sleep duration: what does it mean?. Sleep Med Rev 18 (2014), 291–292.
37. Cho, HJ, Seeman, TE, Kiefe, CI, Lauderdale, DS, Irwin, MR, Sleep disturbance and longitudinal risk of inflammation: moderating influences of social integration and social isolation in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Brain Behav Immun 46 (2015), 319–326.
38. Smagula, SF, Stone, KL, Fabio, A, Cauley, JA, Risk factors for sleep disturbances in older adults: Evidence from prospective studies. Sleep Med Rev 25 (2016), 21–30.
39. O'Connor, MF, Irwin, MR, Links between behavioral factors and inflammation. Clin Pharmacol Ther 87 (2010), 479–482.
40. Irwin, MR, Olmstead, R, Breen, EC, et al. Cognitive behavioral therapy and tai chi reverse cellular and genomic markers of inflammation in late-life insomnia: a randomized controlled trial. Biol Psychiatry 78 (2015), 721–729.
41. Irwin, MR, Olmstead, R, Carrillo, C, et al. Cognitive behavioral therapy vs. Tai Chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial. Sleep 37 (2014), 1543–1552.
42. Irwin, M, Olmstead, R, Breen, E, et al. Tai Chi, cellular inflammation, and transcriptome dynamics in breast cancer survivors with insomnia: a randomized controlled trial. J Natl Cancer Inst 50 (2014), 295–301.
43. Neale, EP, Batterham, MJ, Tapsell, LC, Consumption of a healthy dietary pattern results in significant reductions in C-reactive protein levels in adults: a meta-analysis. Nutr Res 36 (2016), 391–401.
44. Hayashino, Y, Jackson, JL, Hirata, T, et al. Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Metabolism 63 (2014), 431–440.
45. Prather, AA, Epel, ES, Cohen, BE, Neylan, TC, Whooley, MA, Gender differences in the prospective associations of self-reported sleep quality with biomarkers of systemic inflammation and coagulation: findings from the Heart and Soul Study. J Psychiatr Res 47 (2013), 1228–1235.
46. Prather, AA, Vogelzangs, N, Penninx, BW, Sleep duration, insomnia, and markers of systemic inflammation: results from the Netherlands Study of Depression and Anxiety (NESDA). J Psychiatr Res 60 (2015), 95–102.
47. Grandner, MA, Buxton, OM, Jackson, N, Sands-Lincoln, M, Pandey, A, Jean-Louis, G, Extreme sleep durations and increased C-reactive protein: effects of sex and ethnoracial group. Sleep 36 (2013), 769–779.
48. Kennedy, BK, Berger, SL, Brunet, A, et al. Geroscience: linking aging to chronic disease. Cell 159 (2014), 709–713.
49. Carroll, JE, Cole, SW, Seeman, TE, et al. Partial sleep deprivation activates the DNA damage response (DDR) and the senescence-associated secretory phenotype (SASP) in aged adult humans. Brain Behav Immun 51 (2016), 223–229.
50. Carreras, A, Zhang, SX, Peris, E, et al. Chronic sleep fragmentation induces endothelial dysfunction and structural vascular changes in mice. Sleep 37 (2014), 1817–1824.
51. Lasry, A, Ben-Neriah, Y, Senescence-associated inflammatory responses: aging and cancer perspectives. Trends Immunol 36 (2015), 217–228.
52. Campisi, J, Aging, cellular senescence, and cancer. Annu Rev Physiol 75 (2013), 685–705.
53. Prather, AA, Hecht, FM, Epel, ES, Factors related to telomere length. Brain Behav Immun, 53, 2016, 279.
54. Cribbet, MR, Carlisle, M, Cawthon, RM, et al. Cellular aging and restorative processes: subjective sleep quality and duration moderate the association between age and telomere length in a sample of middle-aged and older adults. Sleep 37 (2014), 65–70.
55. Carroll, JE, Esquivel, S, Goldberg, A, et al. Insomnia and telomere length in older adults. Sleep 39 (2016), 559–564.
56. Carroll, JE, Irwin, MR, Levine, M, et al. Epigenetic aging and immune senescence in women with insomnia symptoms: findings from the Women's Health Initiative Study. Biol Psychiatry 81 (2017), 136–144.
57. Chen, BH, Marioni, RE, Colicino, E, et al. DNA methylation-based measures of biological age: meta-analysis predicting time to death. Aging (Albany NY) 8 (2016), 1844–1865.
58. Marioni, RE, Shah, S, McRae, AF, et al. DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol, 16, 2015, 25.
59. van der Kant, R, Goldstein, LS, Cellular functions of the amyloid precursor protein from development to dementia. Dev Cell 32 (2015), 502–515.
60. Kang, JE, Lim, MM, Bateman, RJ, et al. Amyloid-β dynamics are regulated by orexin and the sleep-wake cycle. Science 326 (2009), 1005–1007.
61. Ooms, S, Overeem, S, Besse, K, Rikkert, MO, Verbeek, M, Claassen, JA, Effect of 1 night of total sleep deprivation on cerebrospinal fluid beta-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol 71 (2014), 971–977.
62. Xie, L, Kang, H, Xu, Q, et al. Sleep drives metabolite clearance from the adult brain. Science 342 (2013), 373–377.
63. Plog, BA, Nedergaard, M, The glymphatic system in central nervous system health and disease: past, present, and future. Annu Rev Pathol 13 (2018), 379–394.
64. Aalling, NN, Nedergaard, M, DiNuzzo, M, Cerebral metabolic changes during sleep. Curr Neurol Neurosci Rep, 18, 2018, 57.
65. Achariyar, TM, Li, B, Peng, W, et al. Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation. Mol Neurodegener, 11, 2016, 74.
66. Lee, H, Xie, L, Yu, M, et al. The effect of body posture on brain glymphatic transport. J Neurosci 35 (2015), 11034–11044.
67. Peng, W, Achariyar, TM, Li, B, et al. Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease. Neurobiol Dis 93 (2016), 215–225.
68. Powell, ND, Sloan, EK, Bailey, MT, et al. Social stress up-regulates inflammatory gene expression in the leukocyte transcriptome via β-adrenergic induction of myelopoiesis. Proc Natl Acad Sci USA 110 (2013), 16574–16579.
69. Slavich, GM, Irwin, MR, From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 140 (2014), 774–815.
70. Brosseron, F, Krauthausen, M, Kummer, M, Heneka, MT, Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview. Mol Neurobiol 50 (2014), 534–544.
71. Cunningham, C, Campion, S, Lunnon, K, et al. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry 65 (2009), 304–312.
72. Holmes, C, Cunningham, C, Zotova, E, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology 73 (2009), 768–774.
73. Gisondi, P, Sala, F, Alessandrini, F, et al. Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis. Dermatology 228 (2014), 78–85.
74. Smith, C, Gentleman, SM, Leclercq, PD, et al. The neuroinflammatory response in humans after traumatic brain injury. Neuropathol Appl Neurobiol 39 (2013), 654–666.
75. Fann, JR, Ribe, AR, Pedersen, HS, et al. Long-term risk of dementia among people with traumatic brain injury in Denmark: a population-based observational cohort study. Lancet Psychiatry 5 (2018), 424–431.
76. Iliff, JJ, Chen, MJ, Plog, BA, et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 34 (2014), 16180–16193.
77. Jonsson, T, Stefansson, H, Steinberg, S, et al. Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368 (2013), 107–116.
78. Bradshaw, EM, Chibnik, LB, Keenan, BT, et al. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci 16 (2013), 848–850.
79. Zhang, B, Gaiteri, C, Bodea, LG, et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 153 (2013), 707–720.
80. + inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med 212 (2015), 287–295.
81. Lee, CYD, Daggett, A, Gu, X, et al. Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer's disease models. Neuron 97 (2018), 1032–1048.
82. Kincheski, GC, Valentim, IS, Clarke, JR, et al. Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-β oligomers in mice. Brain Behav Immun 64 (2017), 140–151.
83. Breitner, JC, Zandi, PP, Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease?. N Engl J Med 345 (2001), 1567–1568.
84. Aisen, PS, The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol 1 (2002), 279–284.
85. Graham, WV, Bonito-Oliva, A, Sakmar, TP, Update on Alzheimer's disease therapy and prevention strategies. Annu Rev Med 68 (2017), 413–430.
86. Miguel-Alvarez, M, Santos-Lozano, A, Sanchis-Gomar, F, et al. Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect. Drugs Aging 32 (2015), 139–147.
87. Breitner, JC, Baker, LD, Montine, TJ, et al. Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement 7 (2011), 402–411.
88. Dufouil, C, Glymour, MM, Prediction to prevention in Alzheimer's disease and dementia. Lancet Neurol 17 (2018), 388–389.
89. Norton, S, Matthews, FE, Barnes, DE, Yaffe, K, Brayne, C, Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol 13 (2014), 788–794.
90. Mander, BA, Marks, SM, Vogel, JW, et al. β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nat Neurosci 18 (2015), 1051–1057.
91. Sprecher, KE, Koscik, RL, Carlsson, CM, et al. Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults. Neurology 89 (2017), 445–453.
92. Liguori, C, Romigi, A, Nuccetelli, M, et al. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA Neurol 71 (2014), 1498–1505.
93. Iadecola, C, Yaffe, K, Biller, J, et al. Impact of hypertension on cognitive function: a scientific statement from the American Heart Association. Hypertension 68 (2016), e67–e94.
94. Spira, AP, An, Y, Peng, Y, et al. APOE genotype and nonrespiratory sleep parameters in cognitively intact older adults. Sleep, 40, 2017, zsx076.
95. Qaseem, A, Kansagara, D, Forciea, MA, Cooke, M, Denberg, TD, Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 162 (2016), 125–133.
96. Ngandu, T, Lehtisalo, J, Solomon, A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385 (2015), 2255–2263.
97. Irwin, MR, Innovation in the treatment of insomnia in breast cancer survivors. J Natl Cancer Inst 110 (2018), 799–800.
98. Irwin, MR, Olmstead, R, Carrillo, C, et al. Tai Chi Chih compared with cognitive behavioral therapy for the treatment of insomnia in survivors of breast cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol 35 (2017), 2656–2665.
99. Black, DS, O'Reilly, GA, Olmstead, R, Breen, EC, Irwin, MR, Mindfulness meditation and improvement in sleep quality and daytime impairment among older adults with sleep disturbances: a randomized clinical trial. JAMA Intern Med 175 (2015), 494–501.
100. Goyal, M, Singh, S, Sibinga, EM, et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med 174 (2014), 357–368.
101. Morgan, N, Irwin, MR, Chung, M, Wang, C, The effects of mind-body therapies on the immune system: meta-analysis. PLoS One, 9, 2014, e100903.
102. Bower, JE, Irwin, MR, Mind-body therapies and control of inflammatory biology: a descriptive review. Brain Behav Immun 51 (2016), 1–11.
103. Bower, JE, Crosswell, AD, Stanton, AL, et al. Mindfulness meditation for younger breast cancer survivors: a randomized controlled trial. Cancer 121 (2015), 1231–1240.